Amput, P., Palee, S., Arunsak, B., Pratchayasakul, W., Kerdphoo, S., Jaiwongkam, T., . . . Chattipakorn, N. (2020). PCSK9 inhibitor effectively attenuates cardiometabolic impairment in obese-insulin resistant rats.
Chicago Style CitationAmput, Patchareeya, Siripong Palee, Busarin Arunsak, Wasana Pratchayasakul, Sasiwan Kerdphoo, Thidarat Jaiwongkam, Siriporn C. Chattipakorn, and Nipon Chattipakorn. PCSK9 Inhibitor Effectively Attenuates Cardiometabolic Impairment in Obese-insulin Resistant Rats. 2020.
MLA CitationAmput, Patchareeya, et al. PCSK9 Inhibitor Effectively Attenuates Cardiometabolic Impairment in Obese-insulin Resistant Rats. 2020.
Warning: These citations may not always be 100% accurate.